China has asked local authorities to further lower the price of Covid-19 nucleic acid tests to no more than 16 yuan (nearly $2.4) per person for a single test.
The price for batch testing, which combines samples from up to 10 people in a single test, should be no more than five yuan per person, said a circular made public by the National Healthcare Security Administration on Wednesday.
The administration requires all provincial-level regions to complete the price adjustment by June 10, Xinhua news agency reported.
The move is part of the government's efforts to reduce the cost of nucleic acid testing, an important means to facilitate regular epidemic response.
The nucleic acid test price in China has dropped over the past years from more than 120 yuan per person for a single test to no more than 60 yuan in September 2021, 40 yuan in December 2021, and 28 yuan in April 2022.
The administration also encouraged measures, including centralised procurement of detection reagents, to secure a continuous and reasonable decline in the testing price.
--IANS
int/khz/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
New Year Offer
₹849
₹
New BS Annual Non renewal
₹1,799
₹
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app